Reneo Pharmaceuticals (OKUR) Free Cash Flow (2020 - 2025)
Reneo Pharmaceuticals (OKUR) free cash flow from Mar 31, 2020 to Dec 31, 2025. The TTM Reneo Pharmaceuticals (OKUR) free cash flow is -$52M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Reneo Pharmaceuticals (OKUR) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +1.39% |
| 3 Years TTM | +2.83% |
| 5 Years TTM | +22.81% |
| All Time TTM | +18.95% |
Annual Free Cash Flow change of Reneo Pharmaceuticals (OKUR)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$52M | +1.39% |
| 2024 | -$51M | -19.92% |
| 2023 | -$64M | +33.93% |
| 2022 | -$48M | +24.96% |
| 2021 | -$38M | +105.71% |
| 2020 | -$19M | N/A |
Comparison Reneo Pharmaceuticals (OKUR) five years free cash flow CAGR with competitors
Reneo Pharmaceuticals (OKUR) five years free cash flow CAGR is 22.82%.